https://www.selleckchem.com/products/fm19g11.html
Quantitative cardiovascular magnetic resonance (CMR)T1 and T2 mapping are used to detect diffuse disease such as myocardial fibrosis or edema. However, post gadolinium contrast mapping often lacks visual contrast needed for assessment of focal scar. On the other hand, late gadolinium enhancement (LGE) CMRwhich nulls the normal myocardium has excellent contrast between focal scar and normal myocardium but has poor ability to detect global disease. The objective of this work is to provide a calculated bright-blood (B and dark-blood (D
Like
Comment
Share
